Lagarde M - Search Results

1

Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients.

Pruneta-Deloche V, Ponsin G, Groisne L, Fruchart-Najib J, Lagarde M, Moulin P. Pruneta-Deloche V, et al. Among authors: lagarde m. Atherosclerosis. 2005 Aug;181(2):403-5. doi: 10.1016/j.atherosclerosis.2005.01.034. Epub 2005 Feb 17. Atherosclerosis. 2005. PMID: 16039297

2

Variations in the fatty acid composition of lipid classes from lipoproteins in elderly women.

Lecerf J, Rossignol A, Véricel E, Thiès F, Farnier M, Lagarde M. Lecerf J, et al. Among authors: lagarde m. Atherosclerosis. 1993 Jan 25;98(2):241-9. doi: 10.1016/0021-9150(93)90133-f. Atherosclerosis. 1993. PMID: 8457263

3

Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets.

Coulon L, Calzada C, Moulin P, Véricel E, Lagarde M. Coulon L, et al. Among authors: lagarde m. Free Radic Biol Med. 2003 Sep 15;35(6):616-25. doi: 10.1016/s0891-5849(03)00386-1. Free Radic Biol Med. 2003. PMID: 12957654

4

Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients.

Nivoit P, Wiernsperger N, Moulin P, Lagarde M, Renaudin C. Nivoit P, et al. Among authors: lagarde m. Diabetologia. 2003 Nov;46(11):1550-8. doi: 10.1007/s00125-003-1225-2. Epub 2003 Oct 24. Diabetologia. 2003. PMID: 14576982

5

Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status.

Véricel E, Januel C, Carreras M, Moulin P, Lagarde M. Véricel E, et al. Among authors: lagarde m. Diabetes. 2004 Apr;53(4):1046-51. doi: 10.2337/diabetes.53.4.1046. Diabetes. 2004. PMID: 15047620

6

Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia.

Pruneta-Deloche V, Marçais C, Perrot L, Sassolas A, Delay M, Estour B, Lagarde M, Moulin P. Pruneta-Deloche V, et al. Among authors: lagarde m. J Clin Endocrinol Metab. 2005 Jul;90(7):3995-8. doi: 10.1210/jc.2005-0205. Epub 2005 Apr 19. J Clin Endocrinol Metab. 2005. PMID: 15840743

7

Transfer of very low density lipoprotein-associated phospholipids to activated human platelets.

Ibrahim S, Djimet-Baboun A, Pruneta-Deloche V, Calzada C, Lagarde M, Ponsin G. Ibrahim S, et al. Among authors: lagarde m. J Lipid Res. 2006 Feb;47(2):341-8. doi: 10.1194/jlr.M500209-JLR200. Epub 2005 Nov 17. J Lipid Res. 2006. PMID: 16293890 Free article.

8

Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals.

Bacot S, Bernoud-Hubac N, Chantegrel B, Deshayes C, Doutheau A, Ponsin G, Lagarde M, Guichardant M. Bacot S, et al. Among authors: lagarde m. J Lipid Res. 2007 Apr;48(4):816-25. doi: 10.1194/jlr.M600340-JLR200. Epub 2007 Jan 12. J Lipid Res. 2007. PMID: 17220481 Free article.

9

In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase.

Calzada C, Coulon L, Halimi D, Le Coquil E, Pruneta-Deloche V, Moulin P, Ponsin G, Véricel E, Lagarde M. Calzada C, et al. Among authors: lagarde m. J Clin Endocrinol Metab. 2007 May;92(5):1961-4. doi: 10.1210/jc.2006-2045. Epub 2007 Mar 6. J Clin Endocrinol Metab. 2007. PMID: 17341567

10

The transfer of VLDL-associated phospholipids to activated platelets depends upon cytosolic phospholipase A2 activity.

Ibrahim S, Calzada C, Pruneta-Deloche V, Lagarde M, Ponsin G. Ibrahim S, et al. Among authors: lagarde m. J Lipid Res. 2007 Jul;48(7):1533-8. doi: 10.1194/jlr.M600480-JLR200. Epub 2007 Apr 24. J Lipid Res. 2007. PMID: 17456899 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

571 results

Search Page